Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thorsten M Leucker

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
European Heart Journal. Cardiovascular Pharmacotherapy|July 19, 2023
Platelet activation and endothelial dysfunction biomarkers in acute coronary syndrome: the impact of PCSK9 inhibitionEfthymios Ziogos, Stephen P Chelko, Tarek Harb, et al.
Journal of the American Heart Association|November 22, 2024
Lipoprotein(a) Is Elevated and Inversely Related to Coronary Endothelial Function in People With HIVDaniel S Kikuchi, Yaa A Kwapong, Michael Schär, et al.
Placenta|January 5, 2023
The role of proprotein convertase subtillisin/kexin type 9 in placental salvage and lipid metabolism in women with preeclampsiaArthur Jason Vaught, Theresa Boyer, Efthymios Ziogos, et al.
Open Heart|August 21, 2025
PCSK9 targeting therapies for familial hypercholesterolaemia: a meta-analysis of efficacy on lipid biomarkers and safety in adults and children across 23 RCTsVinh Q T Ho, Nghi Bao Tran, Nhan Nguyen, et al.
JACC. Basic to Translational Science|May 29, 2025
Impact of In-Hospital PCSK9 Inhibition on Myocardial Inflammation After Myocardial Infarction: A Randomized Clinical TrialEfthymios Ziogos, Tarek Harb, Ines Valenta, et al.
JACC. Basic to Translational Science|December 14, 2021
Effect of Crizanlizumab, a P-Selectin Inhibitor, in COVID-19: A Placebo-Controlled, Randomized TrialThorsten M Leucker, William O Osburn, Paula Reventun, et al.
Journal of the American College of Cardiology|December 12, 2024
Intraindividual Variability in Serial Lipoprotein(a) Concentrations Among Placebo-Treated Patients in the OCEAN(a)-DOSE TrialPrakriti Gaba, Robert S Rosenson, J Antonio G López, et al.
European Heart Journal. Imaging Methods and Practice|March 19, 2026
Lipoprotein(a) is associated with coronary inflammation in people with HIV and undetectable HIV RNANadim Nasrallah, Tarek Harb, Mark Atallah, et al.
Brain, Behavior, & Immunity - Health|April 18, 2025
HIV and Low Omega-3 Levels May Heighten Hippocampal Volume Differences Between Men and Women With Substance UseHong Lai, Jiachen Zhuo, Glenn Treisman, et al.
The American Journal of Cardiology|July 10, 2021
Comparison of Ticagrelor Versus Clopidogrel on Cerebrovascular Microembolic Events and Platelet Inhibition during Transcatheter Aortic Valve ImplantationMichael A Vavuranakis, Charalampos Kalantzis, Vassilis Voudris, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
European Heart Journal. Cardiovascular Pharmacotherapy|July 19, 2023
Platelet activation and endothelial dysfunction biomarkers in acute coronary syndrome: the impact of PCSK9 inhibitionEfthymios Ziogos, Stephen P Chelko, Tarek Harb, et al.
Journal of the American Heart Association|November 22, 2024
Lipoprotein(a) Is Elevated and Inversely Related to Coronary Endothelial Function in People With HIVDaniel S Kikuchi, Yaa A Kwapong, Michael Schär, et al.
Placenta|January 5, 2023
The role of proprotein convertase subtillisin/kexin type 9 in placental salvage and lipid metabolism in women with preeclampsiaArthur Jason Vaught, Theresa Boyer, Efthymios Ziogos, et al.
Open Heart|August 21, 2025
PCSK9 targeting therapies for familial hypercholesterolaemia: a meta-analysis of efficacy on lipid biomarkers and safety in adults and children across 23 RCTsVinh Q T Ho, Nghi Bao Tran, Nhan Nguyen, et al.
JACC. Basic to Translational Science|May 29, 2025
Impact of In-Hospital PCSK9 Inhibition on Myocardial Inflammation After Myocardial Infarction: A Randomized Clinical TrialEfthymios Ziogos, Tarek Harb, Ines Valenta, et al.
JACC. Basic to Translational Science|December 14, 2021
Effect of Crizanlizumab, a P-Selectin Inhibitor, in COVID-19: A Placebo-Controlled, Randomized TrialThorsten M Leucker, William O Osburn, Paula Reventun, et al.
Journal of the American College of Cardiology|December 12, 2024
Intraindividual Variability in Serial Lipoprotein(a) Concentrations Among Placebo-Treated Patients in the OCEAN(a)-DOSE TrialPrakriti Gaba, Robert S Rosenson, J Antonio G López, et al.
European Heart Journal. Imaging Methods and Practice|March 19, 2026
Lipoprotein(a) is associated with coronary inflammation in people with HIV and undetectable HIV RNANadim Nasrallah, Tarek Harb, Mark Atallah, et al.
Brain, Behavior, & Immunity - Health|April 18, 2025
HIV and Low Omega-3 Levels May Heighten Hippocampal Volume Differences Between Men and Women With Substance UseHong Lai, Jiachen Zhuo, Glenn Treisman, et al.
The American Journal of Cardiology|July 10, 2021
Comparison of Ticagrelor Versus Clopidogrel on Cerebrovascular Microembolic Events and Platelet Inhibition during Transcatheter Aortic Valve ImplantationMichael A Vavuranakis, Charalampos Kalantzis, Vassilis Voudris, et al.
Pageof 8